Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma, Merkel Cell × antineoplaston AS 2-1 × Clear all

Sponsor

Conditions

Astrocytoma 8 Glioblastoma 5 Neuroectodermal Tumors, Primitive 3 Recurrence 2 Oligodendroglioma 2 Neurocytoma 2 Lymphoma, Non-Hodgkin 2 Glioma 2 Brain Neoplasms 2 Rhabdoid Tumor 1 Pancreatic Neoplasms 1 Neoplasms, Unknown Primary 1 Multiple Myeloma 1 Mesothelioma, Malignant 1 Meningioma 1 Melanoma 1 Lung Neoplasms 1 Gliosarcoma 1 Ganglioglioma 1 Esophageal Neoplasms 1 Ependymoma 1 Craniopharyngioma 1 Carcinoma, Non-Small-Cell Lung 1 Adrenocortical Carcinoma 1 Adenocarcinoma Of Esophagus 1

Interventions

pembrolizumab 8 Nivolumab 5 avelumab 4 Ipilimumab 4 Radiotherapy 2 Radiosurgery 2 ALT-803 2 tremelimumab 1 talimogene laherparepvec 1 sapanisertib 1 prednylidene 1 poly ICLC 1 lenvatinib 1 interferon gamma-1b 1 epacadostat 1 efineptakin alfa 1 durvalumab 1 deltacortene 1 cemiplimab 1 cabozantinib 1 bempegaldesleukin 1 atezolizumab 1 Tacrolimus 1 Radiation Dose Hypofractionation 1 Radiation 1 Prednisone 1 Interferon-gamma 1 Interferon-beta 1 CTLA-4 Antigen 1 B7-H1 Antigen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡